换一批
换一批Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program.
作者：
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);胆道肿瘤(Biliary Tract Neoplasms);顺铂(Cisplatin);脱氧胞苷(Deoxycytidine);女(雌)性(Female);人类(Humans);免疫组织化学(Immunohistochemistry);男(雄)性(Male);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);肿瘤分期(Neoplasm Staging);信号传导(Signal Transduction);治疗结果(Treatment Outcome)
DOI
10.1186/s12885-018-5223-7
PMID
30634942
发布时间
2022-12-07
- 浏览28
BMC cancer
55页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
